Medifast (MED) Reports In-Line Q3 EPS, Offers Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. LRCX
7. LVS
8. CSX
9. QGEN
10. KNX

Go back to Medifast (MED) Reports In-Line Q3 EPS, Offers Guidance

Medifast (MED) Defended at DA Davidson

November 7, 2018 9:53 AM EST

DA Davidson analyst Linda Bolton Weiser reiterated a Buy rating and $249 price target on Medifast (NYSE: MED) telling clients to buy on today's pull-back.

Weiser commented, "MED reported 3Q18 sales of $139M, above consensus of $125M and guidance of $120M-$125M. Revenue growth... More